BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2011

Aug 4, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2011-08-02

Reporting Person: BIENAIME JEAN JACQUES (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-08-02	Common Stock	M	4000	$6.46	Acquired	135093	Direct
2011-08-02	Common Stock	S	4000	$30.23	Disposed	131093	Direct
2011-08-02	Common Stock	S	4000	$30.304	Disposed	127093	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-08-02	Stock Option (right to buy)	$6.46	M	4000	Disposed	2015-05-11	Common Stock (4000)	Direct

Footnotes

F1: Original option grant vested 1/3 each on May 11, 2006, May 11, 2007, and May 11, 2008.

F2: The price in Column 4 is a weighted average price. The prices actually received ranged from $30.0610 to $30.5000. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.